全文获取类型
收费全文 | 2414篇 |
免费 | 295篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 53篇 |
妇产科学 | 33篇 |
基础医学 | 412篇 |
口腔科学 | 31篇 |
临床医学 | 354篇 |
内科学 | 490篇 |
皮肤病学 | 22篇 |
神经病学 | 203篇 |
特种医学 | 72篇 |
外科学 | 333篇 |
综合类 | 72篇 |
一般理论 | 1篇 |
预防医学 | 237篇 |
眼科学 | 37篇 |
药学 | 252篇 |
肿瘤学 | 105篇 |
出版年
2023年 | 13篇 |
2022年 | 25篇 |
2021年 | 62篇 |
2020年 | 27篇 |
2019年 | 43篇 |
2018年 | 53篇 |
2017年 | 47篇 |
2016年 | 45篇 |
2015年 | 51篇 |
2014年 | 64篇 |
2013年 | 89篇 |
2012年 | 136篇 |
2011年 | 138篇 |
2010年 | 63篇 |
2009年 | 72篇 |
2008年 | 141篇 |
2007年 | 149篇 |
2006年 | 135篇 |
2005年 | 172篇 |
2004年 | 143篇 |
2003年 | 155篇 |
2002年 | 138篇 |
2001年 | 59篇 |
2000年 | 66篇 |
1999年 | 50篇 |
1998年 | 30篇 |
1997年 | 29篇 |
1996年 | 26篇 |
1995年 | 11篇 |
1994年 | 29篇 |
1993年 | 20篇 |
1992年 | 30篇 |
1991年 | 40篇 |
1990年 | 32篇 |
1989年 | 32篇 |
1988年 | 27篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1985年 | 16篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1978年 | 19篇 |
1972年 | 14篇 |
1971年 | 10篇 |
1968年 | 8篇 |
1967年 | 12篇 |
排序方式: 共有2717条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
55.
Chung F Barnes N Allen M Angus R Corris P Knox A Miles J Morice A O'Reilly J Richardson M 《Respiratory medicine》2002,96(12):963-975
This review explores the health and social burden of some of the main respiratory diseases (asthma, chronic obstructive pulmonary disease, cryptogenic fibrosing alveolitis, cystic fibrosis, lung cancer, mesothelioma, obstructive sleep apnoea and tuberculosis) in order to increase awareness of these diseases and highlight areas where improvements in care are required. The overall impact of respiratory diseases in the U.K. in terms of prevalence, mortality, morbidity and economic costs, with particular reference to secondary care has been considered and comparisons made with the rest of Europe where data are available. Respiratory diseases are responsible for a significant proportion of serious morbidity and premature death among the population of the U.K. and they will continue to present a growing challenge; special support is needed to tackle this burden. 相似文献
56.
G W Moe T P Stopps C Angus C Forster A J De Bold P W Armstrong 《Journal of the American College of Cardiology》1989,13(1):173-179
The pathophysiologic role of atrial natriuretic factor and other neuroendocrine variables in relation to serum sodium and renal function was evaluated in 15 conscious dogs with severe chronic ventricular pacing-induced heart failure (250 beats/min for 5.1 +/- 0.4 weeks). Six sham-operated dogs observed over an 8 week period served as controls. Development of heart failure was characterized by a progressive increase in plasma norepinephrine, renin activity and aldosterone from control values of 293 +/- 15 pg/ml, 1.4 +/- 0.4 ng/ml per h and 124 +/- 42 pg/ml, respectively, to 1,066 +/- 96 pg/ml, 10.2 +/- 2.4 ng/ml per h and 577 +/- 151 pg/ml (all p less than 0.01), respectively, at severe heart failure. In contrast to other neuroendocrine variables, plasma atrial natriuretic factor increased from a control level of 243 +/- 74 pg/ml to a peak concentration of 724 +/- 149 pg/ml (p less than 0.01) at 2 weeks, then declined and plateaued at twice the level of the control value as severe heart failure developed. At severe heart failure, serum sodium decreased from 147 +/- 0.6 to 141.8 +/- 2.1 mmol/liter (p less than 0.05), whereas urea increased from 6.0 +/- 0.5 to 7.8 +/- 0.6 mmol/liter (p less than 0.05). The change in serum sodium concentration correlated with plasma renin activity and aldosterone (r = -0.77, -0.88, respectively, both p less than 0.01), but not with norepinephrine or atrial natriuretic factor. When sinus rhythm was restored, 14 dogs were observed for 48 to 72 h and 8 dogs were followed up for another 4 weeks after cessation of pacing.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
57.
Itzhak A. Rosner Ali D. Askari Gordon D. Mclaren Angus Muir 《The American journal of medicine》1981,70(4):870-874
A patient manifesting the arthropathy of hemochromatosis without abnormal serum iron studies is described. Hemochromatosis was confirmed by liver biopsy. This case serves to emphasize the diagnostic value of the characteristic arthropathy of hemochromatosis. Our observations in this patient support the hypothesis that the pathogenesis of hereditary hemochromatosis differs from that of acquired iron overload states. The concurrent presence of hypouricemia is explored in this patient and in 18 other patients with hereditary hemochromatosis. Men with hereditary hemochromatosis were found to have lower serum uric acid levels than expected. In our patient, a renal defect in tubular reabsorption of uric acid appears responsible for hypouricemia.The apparent association of hemochromatosis and hypouricemia deserves further investigation. 相似文献
58.
G. S. Hebbard G. Fitt K. R. Thomson P. W. Angus R. Jones R. B. Sewell P. R. Gibson O. Hennessy 《Internal medicine journal》1994,24(2):141-148
Background: The clinical role of the transjugular intrahepatic portal-systemic shunt (TIPS) has not been fully defined.
Aims: To determine the technical results of TIPS and the clinical outcome of patients undergoing the procedure.
Methods: Retrospective audit of the results of the first 31 procedures performed in Melbourne.
Results: Thirty procedures were performed for variceal haemorrhage, one procedure was for ascites. The aetiology of the liver disease was cirrhosis due to alcohol in 20, cryptogenic in five, chronic viral infection in four, and autoimmune chronic active hepatitis in one. Nodular regenerative hyperplasia was present in one patient. Seventy-seven per cent of procedures were considered successful based on the angiographic demonstration of shunt patency at the end of the procedure. The in-hospital mortality in all patients undergoing TIPS was 45% and was 42% in patients undergoing technically successful TIPS. Only age could be identified as predictive of death in hospital. In patients leaving hospital, we found a rebleeding rate of 57% with one patient dying of bleeding, one requiring balloon tamponade and two requiring variceal sclerotherapy. Hepatic trauma was documented in six cases, shunt thrombosis in four cases, stent displacement in two cases and severe hepatic encephalopathy in one case.
Conclusions: TIPS has the potential to decompress the portal venous system, but the procedure is technically complex and should be performed in the knowledge that mortality and morbidity can be relatively high, particularly in patients whose condition is poor. 相似文献
Aims: To determine the technical results of TIPS and the clinical outcome of patients undergoing the procedure.
Methods: Retrospective audit of the results of the first 31 procedures performed in Melbourne.
Results: Thirty procedures were performed for variceal haemorrhage, one procedure was for ascites. The aetiology of the liver disease was cirrhosis due to alcohol in 20, cryptogenic in five, chronic viral infection in four, and autoimmune chronic active hepatitis in one. Nodular regenerative hyperplasia was present in one patient. Seventy-seven per cent of procedures were considered successful based on the angiographic demonstration of shunt patency at the end of the procedure. The in-hospital mortality in all patients undergoing TIPS was 45% and was 42% in patients undergoing technically successful TIPS. Only age could be identified as predictive of death in hospital. In patients leaving hospital, we found a rebleeding rate of 57% with one patient dying of bleeding, one requiring balloon tamponade and two requiring variceal sclerotherapy. Hepatic trauma was documented in six cases, shunt thrombosis in four cases, stent displacement in two cases and severe hepatic encephalopathy in one case.
Conclusions: TIPS has the potential to decompress the portal venous system, but the procedure is technically complex and should be performed in the knowledge that mortality and morbidity can be relatively high, particularly in patients whose condition is poor. 相似文献
59.
Field AE Gillman MW Rosner B Rockett HR Colditz GA 《International journal of obesity (2005)》2003,27(7):821-826
OBJECTIVE: To assess whether intake of fruits and vegetables was associated with change in body mass index (BMI) among a large sample of children and adolescents in the United States. DESIGN: Prospective cohort study of children and adolescent who were 9-14 y of age in 1996, when the study began. SUBJECTS: The subjects included 8203 girls and 6715 boys in an ongoing cohort study who completed at least two questionnaires between 1996 and 1999. MEASUREMENTS: Fruit and vegetable intake was assessed in 1996-1998 with a validated food frequency questionnaire designed specifically for children and adolescents. The outcome measure was change in age- and gender-specific z-score of BMI (kg/m(2)). Self-reported weight and height, which were used to calculate BMI, were collected annually from 1996 to 1999. RESULTS: During 3 years of follow-up, annual changes in BMI were slightly greater among the boys than the girls. After controlling for Tanner stage of development, age, height change, activity and inactivity, which are known or suspected predictors of change in BMI, among the girls there was no relation between intake of fruits, fruit juice, or vegetables (alone or combined) and subsequent changes in BMI z-score. Among the boys, intake of fruit and fruit juice was not predictive of changes in BMI, however, vegetables intake was inversely related to changes in BMI z-score (beta per serving=-0.003). However, after adjusting for caloric intake, the magnitude of the effect was diminished and no longer significant. CONCLUSION: Our results suggest that the recommendation for consumption of fruits and vegetables may be well founded, but should not be based on a beneficial effect on weight regulation. 相似文献
60.
M. Harris P. Gibbs J. Cebon R. Jones R. Sewell T. Schelleman P. Angus 《Internal medicine journal》2001,31(9):517-522
Abstract
Background : Chemoembolization is often used in the treatment of hepatocellular carcinoma; however, there are limited data on its efficacy in an Australian setting.
Aims : To review retrospectively the experience of 21 patients with hepatocellular carcinoma who collectively had 36 chemoembolizations performed between October 1995 and February 1999 in a teaching hospital and liver transplant centre in Victoria.
Methods : Selective catheterization of the right or left hepatic arteries was performed. A mixture of cis-platin 50 mg, epirubicin 50 mg, mitomycin C 10 mg, Lipiodol and gelfoam was injected. Computed tomography (CT) scans were performed at baseline and at 1–3 months after chemoembolization. Outcome measures included response rates, toxicity, progression-free and overall survival.
Results : CT response rates: partial response 19% ( n = 7), median duration 11 months (range 2+ to 37+); minor response 17% ( n = 6), median duration 7 months (1+ to 12+); stable disease 42% ( n = 15), median duration 3 months (1+ to 15 months); and progressive disease 22% ( n = 8). Major toxicities included one case each of acute renal failure, contrast encephalopathy, gastric ulceration and hepatorenal failure. Median progression-free survival was 3 months (range 0–37+). Median overall survival was 15 months (range 6–50+).
Conclusion : Chemoembolization has a role in the palliative treatment of hepatocellular carcinoma. Our response rates and toxicity data are consistent with those in the published literature. However, new treatments are needed and prevention of disease by reduction in the prevalence of chronic hepatitis B and C will be required to significantly reduce mortality from this tumour. (Intern Med J 2001; 31: 517–522. 相似文献
Background : Chemoembolization is often used in the treatment of hepatocellular carcinoma; however, there are limited data on its efficacy in an Australian setting.
Aims : To review retrospectively the experience of 21 patients with hepatocellular carcinoma who collectively had 36 chemoembolizations performed between October 1995 and February 1999 in a teaching hospital and liver transplant centre in Victoria.
Methods : Selective catheterization of the right or left hepatic arteries was performed. A mixture of cis-platin 50 mg, epirubicin 50 mg, mitomycin C 10 mg, Lipiodol and gelfoam was injected. Computed tomography (CT) scans were performed at baseline and at 1–3 months after chemoembolization. Outcome measures included response rates, toxicity, progression-free and overall survival.
Results : CT response rates: partial response 19% ( n = 7), median duration 11 months (range 2+ to 37+); minor response 17% ( n = 6), median duration 7 months (1+ to 12+); stable disease 42% ( n = 15), median duration 3 months (1+ to 15 months); and progressive disease 22% ( n = 8). Major toxicities included one case each of acute renal failure, contrast encephalopathy, gastric ulceration and hepatorenal failure. Median progression-free survival was 3 months (range 0–37+). Median overall survival was 15 months (range 6–50+).
Conclusion : Chemoembolization has a role in the palliative treatment of hepatocellular carcinoma. Our response rates and toxicity data are consistent with those in the published literature. However, new treatments are needed and prevention of disease by reduction in the prevalence of chronic hepatitis B and C will be required to significantly reduce mortality from this tumour. (Intern Med J 2001; 31: 517–522. 相似文献